Context Therapeutics Inc. (CNTX)
0.98
-0.01 (-1.02%)
At close: Jan 15, 2025, 3:59 PM
0.98
0.01%
After-hours Jan 15, 2025, 04:56 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -23.96M | -14.84M | -10.46M | 6.64M | -6.38M |
| Depreciation & Amortization | 12.04K | 9.27K | n/a | n/a | n/a |
| Stock-Based Compensation | 1.08M | 976.44K | 511.08K | 219.25K | 775.25K |
| Other Working Capital | 329.03K | 510.37K | -1.36M | 762.03K | 56.38K |
| Other Non-Cash Items | 51.97K | 578.52K | 3.37M | -9.22M | 2.21M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.78M | -277.52K | -2.22M | 1.32M | 561.79K |
| Operating Cash Flow | -21.05M | -13.55M | -8.80M | -1.03M | -2.84M |
| Capital Expenditures | n/a | -536.84K | -250.00K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -500 | -250.00K | n/a | n/a |
| Investing Cash Flow | n/a | -536.84K | -250.00K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 149.05K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -102.07K | 4.98M | 1.00M | 1.96M |
| Financial Cash Flow | n/a | -102.07K | 58.39M | 1.15M | 1.96M |
| Net Cash Flow | -21.05M | -14.19M | 49.34M | 114.43K | -878.69K |
| Free Cash Flow | -21.05M | -14.09M | -9.05M | -1.03M | -2.84M |